ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,675 | -3,627 | -7,584 | -5,910 | -4,217 |
| Depreciation Amortization | 22 | 10 | 90 | 80 | 62 |
| Accounts receivable | -7 | -16 | 10,496 | 6,928 | 6,933 |
| Other Working Capital | 1,225 | 863 | 7,609 | 4,703 | 5,284 |
| Other Operating Activity | 1,289 | 309 | -9,870 | -6,357 | -6,545 |
| Operating Cash Flow | $-7,145 | $-2,460 | $740 | $-556 | $1,516 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,916 | -68 | -11,210 | -157 | -108 |
| PPE Investments | -129 | -15 | -29 | -8 | -7 |
| Investing Cash Flow | $1,787 | $-83 | $-11,239 | $-165 | $-115 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34 | N/A | 18,495 | 18,470 | 18,327 |
| Financing Cash Flow | $34 | $N/A | $18,495 | $18,470 | $18,327 |
| Beginning Cash Position | 15,649 | 15,649 | 7,654 | 7,654 | 7,654 |
| End Cash Position | 10,326 | 13,106 | 15,649 | 25,403 | 27,382 |
| Net Cash Flow | $-5,323 | $-2,543 | $7,995 | $17,749 | $19,728 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,145 | -2,460 | 740 | -556 | 1,516 |
| Capital Expenditure | -129 | -15 | -29 | -8 | -7 |
| Free Cash Flow | -7,273 | -2,475 | 711 | -564 | 1,509 |